Royalty Report: Therapeutic, Medical, Device – Collection: 266122

$100.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 3

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3

Primary Industries

  • Therapeutic
  • Medical
  • Device
  • Skin care
  • Surgical
  • Drugs
  • Cancer
  • Diagnostic
  • Pharmaceuticals

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 266122

License Grant
The Company agreed to purchase the rights to the Licensors U.S. Patent No. 7,963,959.
License Property
U.S. Patent No. 7,963,959 'Automated Cryogenic Skin Treatment'.
Field of Use
This agreement pertains to the healthcare industry relating to an apparatus and methods for treating lesions on skin.

IPSCIO Record ID: 203491

License Grant
The University hereby grants to the Licensee a co-exclusive license (with New Star) to the Regents Patent Rights, for the following fields of use (i) for procedures that involve non-ablative laser skin rejuvenation including collagen formation, collagen remodeling, skin smoothing and wrinkle treatment, (ii) for procedures that involve the treatment of facial and lower extremities telangiestasias and spider veins and (iii) for procedures using a long pulse [0.2 – 500 milliseconds] 1.06 UM Nd.YAG laser (collectively, the 'Co-exclusive Fields of Use') and grants to the Licensee an exclusive license to the Regents Patent Rights for the following fields of use for procedures that involve (i) vascular skin lesions and (ii) laser hair removal (collectively, the 'Exclusive Fields of Use'), to make, have made, use, sell, offer for sale, and import Patent Products and to practice the Patent Method. The Regents hereby grants to Licensee a non-exclusive license under The Regents Patent Rights to make, have made, use, sell, offer for sale, and import Patent Products and to practice the Patent Method in any fields of use not covered by the Co-exclusive Fields of Use and the Exclusive Fields of Use. The Regents specifically retains all rights to grant Further Licenses to The Regents Patent Rights to any party for fields of use not covered by the Co-Exclusive Fields of Use and the Exclusive Fields of Use.

This Agreement grants the exclusive right, co-exclusive right, or nonexclusive right to use or sell the Patent Products in the United States within specified fields of use, Licensee agrees that any Patent Products embodying the Regents Patent Rights or produced through the use thereof will be manufactured substantially in the United States.

License Property
Regents Patent Rights means all U.S. patents and patent applications and foreign patents and patent  applications assigned to The Regents, including any reissues, extensions, substitutions, continuations, divisions and continuations-in-part (only to the extent, however, that claims in any continuations-in-part not listed below are entitled to the priority filing date of any of the below listed patents and patent applications) based on and including any subject matter claimed in or covered in U.S. Patent Application Serial Number 08/222,976 entitled 'Apparatus and Method for Dynamic Cooling of Biological Tissues for Thermal Mediated Surgery' now  abandoned; filed April 5, 1994; and assigned to The Regents. As of the effective date of this Agreement, the Regents Patent Rights include the following patents and patent applications
93-364-2            08/441930                                US    5,814,040 issued 09/29/98
Apparatus and method for dynamic cooling of biological tissues for thermal mediated surgery
93-364-3            08/870467                                US   5,979,454 issued 11/09/99
Method and apparatus for causing rapid and deep spatially selective coagulation during thermally mediated therapeutic procedures
93-364-4            08/963531                                US   6,171,301 B1 issued 01/09/01
Apparatus and method for dynamic cooling of biological tissues for thermal mediated surgery

Patent Products means any kit, composition of matter, material, or product whose manufacture, use, or sale in a particular country would infringe, but for the license granted to Licensee pursuant to this Agreement, an unexpired Claim of a patent or pending claim of a patent application under Regents Patent Rights in that country in which such patent has issued or application is pending; any kit, composition of matter, material, or product to be used in a manner requiring the performance of the Patent Method; or any kit, composition of matter, material, or product produced by the Patent Method. This definition of Patent Products also includes a service either used by Licensee or provided by Licensee to its customers when such service requires the practice of the Patent Method. Dynamic Cooling Device (or DCD) means a cooling device for use with a laser system, the combination of which utilizes the Regents Patent Rights. DCDs, whether sold as (i) an accessory or upgrade product to a laser system or (ii) integrated with a laser system as one product, are Patent Products.

Field of Use
Dynamic Cooling Device (DCD) is a device which cools the top layer of the skin, while leaving the targeted underlying hair follicle, vein or other structure at normal temperature. As a result, higher levels of laser energy can be delivered during treatment, while minimizing thermal injury, pain, and the inconvenience associated with anesthetics. The design of the hand-held DCD enables the practitioner to clearly see the area being treated, and the combined efficiency of the lasers and DCD reduces the risks of over treatment. The DCD delivers the appropriate amount of cooling quickly and consistently.

IPSCIO Record ID: 1634

License Grant
The Company has been granted an exclusive worldwide license (with a right to sublicense) by Canadian Licensee to make, have made, use and sell products which are precursors of PpIX, including ALA, under Licensor patent rights; brand of 5-aminolevulinic acid (ALA); method for detecting and/or treating primary or secondary malignant and non-malignant tissue abnormalities and lesions of the skin; conjunctiva; respiratory, digestive and vaginal mucosa; endometrium and urothelium in which a precursor to protoporphyrin IX, including 5-amino levulinic acid (ALA).
License Property
Methods of Diagnosis and/or Treatment Using Photodynamic Therapy Compositions for Detection or Treatment-U.S. Patent 5,079,262; 5,211,938; 5,234,940; 5,422,093.
Field of Use
The rights granted apply to the skin.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.